Treatment of pulmonary brucellosis: a systematic review

Expert Rev Anti Infect Ther. 2017 Jan;15(1):33-42. doi: 10.1080/14787210.2017.1254042. Epub 2016 Nov 10.

Abstract

Pulmonary involvement is a rare, focal complication of human brucellosis. The aim of this review is to describe clinical and radiologic features, treatment administered and clinical course of these patients. Areas covered: We conducted a systematic search of scientific reports of brucellosis with pulmonary involvement published from January 1985 to July 2016. Four main patterns of disease were observed: pneumonia, pleural effusion, nodules and interstitial pattern. Cough and fever were the most common symptoms. Brucella spp. culture was obtained from blood (50%) or pleural fluid. Treatment is based on the same antibiotics and combinations of antibiotics as for patients with acute no complicated brucellosis. The most frequent antimicrobial combination was doxycycline and rifampin for six weeks. The clinical course was favorable in most reports, and mortality was remarkably low (<1%). Expert commentary: Non-specific clinical and radiological manifestations were the main reason for the delay in proper treatment. Difficulty in distinguishing Brucellosis from other pulmonary infections, such as tuberculosis, sometimes posed an added diagnostic challenge.

Keywords: Brucella melitensis; Brucellosis; aminoglycosides; antimicrobial treatment; focal complication; pleural effusion; pulmonary infection; pulmonary patter; rifampin; tetracyclines.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Brucellosis / blood
  • Brucellosis / diagnostic imaging
  • Brucellosis / drug therapy*
  • Brucellosis / microbiology
  • Drug Therapy, Combination
  • Humans
  • Lung Diseases / blood
  • Lung Diseases / diagnostic imaging
  • Lung Diseases / drug therapy*
  • Lung Diseases / microbiology
  • Practice Guidelines as Topic
  • Respiration, Artificial

Substances

  • Anti-Bacterial Agents